Drugs News and Research

RSS

Researchers identify neurons that regulate nausea-like responses in mice

At some point, everyone experiences nausea. Whether it occurs after unwisely eating a week-old slice of pizza or as an accompaniment to a serious infection, that queasy, unsettling sensation centered around the stomach is a signal that something is amiss within the body and typically portends a bout of vomiting.

17 Dec 2020

Researchers examine proteins involved in SARS-CoV-2 infection

Like all viruses, the novel coronavirus is dependent on help from the human host cell. Proteins are the functional units of the cell and enable the virus to enter the host cell or help the virus to replicate.

17 Dec 2020

Fluorescence guidance can enable surgeons to assess cancer tissues in real-time

A clinical research study published in the British Journal of Surgery shows that fluorescence guidance (where a fluorescent chemical compound re-emits light with a long wavelength) can enable a colorectal surgeon to assess cancer tissues visually and with more specificity in real-time during surgery, by utilising near-infrared (NIR) light from an administered fluorophore in conjunction with artificial intelligence (AI) methods.

17 Dec 2020

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

17 Dec 2020

Harvard Medical professor wins Berggruen Prize for transforming perception of infectious diseases

Paul Farmer, the Kolokotrones University Professor and chair of the Department of Global Health and Social Medicine in the Blavatnik Institute at Harvard Medical School, was selected as the winner of the 2020 Berggruen Prize for Philosophy and Culture.

16 Dec 2020

PrEP prescription can make a positive difference in women who inject drugs

When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effective way to prevent HIV transmission, according to the Centers for Disease Control and Prevention.

16 Dec 2020

Oral hormone therapy significantly alters the metabolome of postmenopausal women

Groundbreaking research led by a team of scientists including a University of Massachusetts Amherst biostatistician shows that oral hormone therapy (HT) significantly alters the metabolome of postmenopausal women.

16 Dec 2020

New screening platform can be used to discover more effective drugs for type 1 diabetes

With nearly 2 million Americans battling type 1 diabetes, it is no surprise that clinical therapies for the disease are constantly evolving and improving.

16 Dec 2020

Lipid mediators can enhance regeneration of inflamed periodontal tissue

Maresin and resolvin, produced by the body from omega-3 fatty acids, can help repair tissue damaged by periodontal disease.

16 Dec 2020

UH researcher examines whether early drug intervention can curb weight gain in mentally ill children

A University of Houston pharmacological researcher believes that prescribing the drug Metformin for children and teens as soon as they are diagnosed with mental illnesses, like bipolar disorder and schizophrenia, may save them from gaining an enormous amount of weight.

16 Dec 2020

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

Today, the U.S. Food and Drug Administration issued a new emergency use authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test which is authorized for use by patients at home with a prescription.

16 Dec 2020

Researchers focus on preventing infections caused by carbapenemase-producing bacteria

In 2017, the World Health Organization published a list of pathogens for which new drugs are urgently needed.

16 Dec 2020

Researchers identify new biomarkers associated with incident heart failure

Researchers at the University of Eastern Finland and Kuopio University Hospital have discovered several new biomarkers that are associated with incident heart failure.

16 Dec 2020

Discovery about DNA repair enzyme could lead to new treatments for certain cancers

Researchers at the Francis Crick Institute have found a new way to prevent some tumours from repairing their own DNA, a function that is essential for cancer cell survival.

16 Dec 2020

FDA grants marketing authorization for new ACL implant

Today, the U.S. Food and Drug Administration granted marketing authorization—under the De Novo premarket review pathway—for an anterior cruciate ligament (ACL) implant, intended to serve as an alternative to ACL reconstruction to treat ACL tears.

16 Dec 2020

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

As researchers continue to search for antivirals to counter COVID-19, a study presents the potential utility of a decoction called Respiratory Detox Shot (RDS).

16 Dec 2020

Azithromycin trial fails to provide evidence of benefit in COVID-19

Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.

16 Dec 2020

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

The second wave of COVID-19 has affected many countries, costing thousands of lives and dealing further heavy blows to already reeling economies.

16 Dec 2020

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients.

From AXT Pty Ltd 16 Dec 2020

RedHill Biopharma announces promising preliminary results from opaganib study

TEL AVIV, Israel and RALEIGH, NC, December 15, 2020, RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study with opaganib.

15 Dec 2020

Drugs News and Research

Researchers identify neurons that regulate nausea-like responses in mice

Researchers examine proteins involved in SARS-CoV-2 infection

Fluorescence guidance can enable surgeons to assess cancer tissues in real-time

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Harvard Medical professor wins Berggruen Prize for transforming perception of infectious diseases

PrEP prescription can make a positive difference in women who inject drugs

Oral hormone therapy significantly alters the metabolome of postmenopausal women

New screening platform can be used to discover more effective drugs for type 1 diabetes

Lipid mediators can enhance regeneration of inflamed periodontal tissue

UH researcher examines whether early drug intervention can curb weight gain in mentally ill children

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

Researchers focus on preventing infections caused by carbapenemase-producing bacteria

Researchers identify new biomarkers associated with incident heart failure

Discovery about DNA repair enzyme could lead to new treatments for certain cancers

FDA grants marketing authorization for new ACL implant

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Azithromycin trial fails to provide evidence of benefit in COVID-19

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

RedHill Biopharma announces promising preliminary results from opaganib study

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News